Bo Liu

Dr. Bo Liu

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
RORebeca Ortega
Rebeca Ortega
BLBo Liu
Bo Liu
SPShanta J. Jean Persaud
Shanta J. Jean Persaud
MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally inhibit gene expression. These small molecules are involved in several biological conditions such as inflammation, cell growth and proliferation, and regulation of energy metabolism. In the context of metabolic and cardiovascular diseases, miR-33 is of particular interest as it has been implicated in the regulation of lipid and glucose metabolism. This miRNA is located in introns harboured in the genes encoding sterol regulatory element-binding protein (SREBP)-1 and SREBP-2, which are key transcription factors involved in lipid biosynthesis and cholesterol efflux. This review outlines the role of miR-33 in a range of metabolic and cardiovascular pathologies, such as dyslipidaemia, nonalcoholic fatty liver disease (NAFLD), obesity, diabetes, atherosclerosis, and abdominal aortic aneurysm (AAA), and it provides discussion about the effectiveness of miR-33 deficiency as a possible therapeutic strategy to prevent the development of these diseases.

25 September 2012 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Open access
PDF file
BLBo Liu
Bo Liu
PTPhilip Thacker
Philip Thacker
JMJohn McKinnon
John McKinnon
PYPeiqiang Yu
Peiqiang Yu
Background: Dried distillers grains with solubles (DDGS) have been extensively utilised in ruminant rations in western Canada and USA, and it is important to ensure their consistent quality. Traditional chemical methods do not consider the inherent structural changes of feed ingredients. Synchrotron‐based Fourier transform infrared microspectroscopy (SFTIRM) and diffuse reflectance infrared Fourier transform spectroscopy (DRIFT) have been utilised to detect the changes in molecular structure of several feedstuffs (e.g. barley, flaxseed and alfalfa). However, similar structural information is lacking for DDGS. The objectives of this study were to identify differences in protein molecular structures between different grains (wheat, triticale and corn) and DDGS (wheat DDGS, triticale DDGS, corn DDGS and wheat and corn blend DDGS) using SFTIRM and DRIFT and to reveal the relationship between changes in protein molecular structure and the digestive characteristics of the protein in DDGS when fed to dairy cattle.Results: The protein molecular structure studies showed significant decreases (P < 0.01) in the amide I to amide II ratio and the α‐helix to β‐sheet ratio between grains and their DDGS. Protein digestive characteristics were correlated with protein molecular structures in grains and DDGS, and prediction equations were established to estimate protein digestive characteristics of DDGS using protein molecular structure parameters. For the DVE/OEB‐1994 model, one of the best prediction equations was for truly absorbed protein in the small intestine (DVE) = 296.17 − 38.98 × the amide I to amide II ratio (R2 = 0.72). For the NRC‐2001 system, one of the best prediction equations was for metabolisable protein (MP) = 300.96 − 43.32 × the amide I to amide II ratio (R2 = 0.76).Conclusion: Protein molecular structure varies between different DDGS and their original grains, and this variation is associated with the digestive characteristics of the proteins in the DDGS and their original grains.

11 July 2022 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
BLBo Liu
Bo Liu
IRInmaculada Ruz-Maldonado
Inmaculada Ruz-Maldonado
KTKlaudia Toczyska
Klaudia Toczyska
OOOladapo E. Olaniru
Oladapo E. Olaniru
MZMohammed Gulrez Zariwala
Mohammed Gulrez Zariwala
SPShanta J. Jean Persaud
Shanta J. Jean Persaud
Aim: This study investigated whether therapeutically relevant concentrations of fluoxetine, which have been shown to reduce plasma glucose and glycated haemoglobin independent of changes in food intake and body weight, regulate beta‐cell function and improve glucose homeostasis. Methods: Cell viability, insulin secretion, beta‐cell proliferation and apoptosis were assessed after exposure of MIN6 beta cells or isolated mouse and human islets to 0.1, 1 or 10 μmol/L fluoxetine. The effect of fluoxetine (10 mg/kg body weight) administration on glucose homeostasis and islet function was also examined in ob/ob mice. Results: Exposure of MIN6 cells and mouse islets to 0.1 and 1 μmol/L fluoxetine for 72 hours did not compromise cell viability but 10 μmol/L fluoxetine significantly increased Trypan blue uptake. The dose of 1 μmol/L fluoxetine significantly increased beta‐cell proliferation and protected islet cells from cytokine‐induced apoptosis. In addition, 1 μmol/L fluoxetine induced rapid and reversible potentiation of glucose‐stimulated insulin secretion from islets isolated from mice, and from lean and obese human donors. Finally, intraperitoneal administration of fluoxetine to ob/ob mice over 14 days improved glucose tolerance and resulted in significant increases in beta‐cell proliferation and enhanced insulin secretory capacity. Conclusions: These data are consistent with a role for fluoxetine in regulating glucose homeostasis through direct effects on beta cells. Fluoxetine thus demonstrates promise as a preferential antidepressant for patients with concomitant occurrence of depression and diabetes.

31 January 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
Patricio AtanesPatricio Atanes
Patricio Atanes
IRInmaculada Ruz-Maldonado
Inmaculada Ruz-Maldonado
RHRoss Hawkes
Ross Hawkes
BLBo Liu
Bo Liu
SPShanta J. Jean Persaud
Shanta J. Jean Persaud
SAStefan Amisten
Stefan Amisten
Background/Aims: CRISPR-Cas9, a RNA-guided targeted genome editing tool, has revolutionized genetic engineering by offering the ability to precisely modify DNA. GPRC5B is an orphan receptor belonging to the group C family of G protein-coupled receptors (GPCRs). In this study, we analysed the functional roles of the Gprc5b receptor in MIN6 β-cells using CRISPR-Cas9 and transient over-expression of Gprc5b. Methods: The optimal transfection reagent for use in MIN6 β-cells was determined by analysing efficiency of GFP plasmid delivery by cell sorting. A MIN6 β-cell line in which Gprc5b expression was knocked down (Gprc5b KD) was generated using CRISPR-Cas9 technology. Gprc5b receptor mRNA expression, proliferation, apoptosis, Cignal 45-Pathway Reporter Array signalling and western blot assays were carried out using Gpcr5b KD MIN6 β-cells that had been transiently transfected with different concentrations of mouse Gprc5b plasmid to over-express Gprc5b. Results: JetPRIME® was the best candidate for MIN6 β-cell transfection, providing approximately 30% transfection efficiency. CRISPR-Cas9 technology targeting Gprc5b led to stable knock-down of this receptor in MIN6 β-cells and its re-expression induced proliferation and potentiated cytokine- and palmitate-induced apoptosis. The Cignal 45 Reporter analysis indicated Gprc5b-dependent regulation of apoptotic and proliferative pathways, and western blotting confirmed activation of signalling via TGF-β and IFNγ. Conclusion: This study provides evidence of CRISPR-Cas9 technology being used to down-regulate Gprc5b expression in MIN6 β-cells. This strategy allowed us to identify signalling pathways linking GPRC5B receptor expression to β-cell proliferation and apoptosis.

1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
MCMei-Chun Chen
Mei-Chun Chen
TLTian-Tian Liu
Tian-Tian Liu
JWJie-Ping Wang
Jie-Ping Wang
YCYan-Ping Chen
Yan-Ping Chen
QCQing-Xi Chen
Qing-Xi Chen
BLBo Liu
Bo Liu
Lipopeptides have been reported to exhibit anti-obesity effects. In this study, we obtained a Bacillus velezensis strain FJAT-52631 that could coproduce iturins, fengycins, and surfactins. Results showed that the FJAT-52631 crude lipopeptide, purified fengycin, iturin, and surfactin standards exhibited strong inhibition activities against lipase with dose-dependence manners (half maximal inhibitory concentration (IC50) = 0.011, 0.005, 0.056, and 0.005 mg/mL, respectively). Moreover, fengycin and surfactin had the comparable activities with orlistat, but iturin not. It was revealed that the inhibition mechanism and type of the lipopeptides were reversible and competitive. The quenching mechanism of lipase was static and only one binding site between lipase and lipopoeptide was inferred from the fluorescence analysis. The docking analysis displayed that fengycin and surfactin could directly interact with the active amino acid residues (Ser or Asp) of lipase, but not with iturin. Our work suggests that the B. velezensis lipopeptides would have great potential to act as lipase inhibitors.

7 August 2024 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Open access
BLBo Liu
Bo Liu
IRInmaculada Ruz-Maldonado
Inmaculada Ruz-Maldonado
SPShanta J. Jean Persaud
Shanta J. Jean Persaud
Aim: To investigate the effect of G protein‐coupled receptor 55 (GPR55) deletion on glucose homeostasis and islet function following diet‐induced obesity. Methods: GPR55 −/− and wild‐type (WT) mice were fed ad libitum either standard chow (SC) or a high‐fat diet (HFD) for 20 weeks. Glucose and insulin tolerance tests were performed at 9/10 and 19/20 weeks of dietary intervention. Insulin secretion in vivo and dynamic insulin secretion following perifusion of isolated islets were also determined, as were islet caspase‐3/7 activities and β‐cell 5‐bromo‐20‐deoxyuridine (BrdU) incorporation. Results: GPR55 −/− mice fed a HFD were more susceptible to diet‐induced obesity and were more glucose intolerant and insulin resistant than WT mice maintained on a HFD. Islets isolated from HFD‐fed GPR55 −/− mice showed impaired glucose‐ and pcacahorbol 12‐myristate 13‐acetate‐stimulated insulin secretion, and they also displayed increased cytokine‐induced apoptosis. While there was a 5.6 ± 1.6‐fold increase in β‐cell BrdU incorporation in the pancreases of WT mice fed a HFD, this compensatory increase in β‐cell proliferation in response to the HFD was attenuated in GPR55 −/− mice. Conclusions: Under conditions of diet‐induced obesity, GPR55 −/− mice show impaired glucose handling, which is associated with reduced insulin secretory capacity, increased islet cell apoptosis and insufficient compensatory increases in β‐cell proliferation. These observations support that GPR55 plays an important role in positively regulating islet function.